DekaBank Deutsche Girozentrale decreased its position in shares of Marsh & McLennan Companies, Inc. (NYSE:MMC - Free Report) by 1.5% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,175,283 shares of the financial services provider's stock after selling 18,008 shares during the quarter. DekaBank Deutsche Girozentrale owned approximately 0.24% of Marsh & McLennan Companies worth $280,074,000 at the end of the most recent reporting period.
Several other hedge funds also recently modified their holdings of MMC. Brighton Jones LLC boosted its holdings in shares of Marsh & McLennan Companies by 51.2% during the 4th quarter. Brighton Jones LLC now owns 8,738 shares of the financial services provider's stock valued at $1,856,000 after acquiring an additional 2,960 shares in the last quarter. Bank Pictet & Cie Europe AG acquired a new stake in shares of Marsh & McLennan Companies during the 4th quarter valued at $37,178,000. Proficio Capital Partners LLC lifted its holdings in Marsh & McLennan Companies by 40.1% during the 4th quarter. Proficio Capital Partners LLC now owns 3,244 shares of the financial services provider's stock worth $689,000 after buying an additional 928 shares during the period. Mesirow Financial Investment Management Inc. lifted its holdings in Marsh & McLennan Companies by 10.5% during the 4th quarter. Mesirow Financial Investment Management Inc. now owns 1,050 shares of the financial services provider's stock worth $223,000 after buying an additional 100 shares during the period. Finally, OFI Invest Asset Management acquired a new position in Marsh & McLennan Companies during the 4th quarter worth about $531,000. Institutional investors and hedge funds own 87.99% of the company's stock.
Marsh & McLennan Companies Stock Up 0.2%
Marsh & McLennan Companies stock traded up $0.47 during midday trading on Thursday, reaching $214.64. The stock had a trading volume of 2,122,020 shares, compared to its average volume of 1,973,774. Marsh & McLennan Companies, Inc. has a 12 month low of $207.21 and a 12 month high of $248.00. The company has a market capitalization of $105.76 billion, a P/E ratio of 26.30, a PEG ratio of 2.61 and a beta of 0.80. The company has a fifty day moving average price of $223.20 and a two-hundred day moving average price of $224.68. The company has a current ratio of 1.14, a quick ratio of 1.14 and a debt-to-equity ratio of 1.32.
Marsh & McLennan Companies (NYSE:MMC - Get Free Report) last issued its quarterly earnings data on Thursday, April 17th. The financial services provider reported $3.06 EPS for the quarter, topping analysts' consensus estimates of $3.02 by $0.04. The firm had revenue of $6.70 billion during the quarter, compared to analyst estimates of $7.08 billion. Marsh & McLennan Companies had a return on equity of 32.19% and a net margin of 16.13%. During the same period in the previous year, the company posted $2.89 EPS. As a group, equities analysts expect that Marsh & McLennan Companies, Inc. will post 9.61 EPS for the current fiscal year.
Marsh & McLennan Companies Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 15th. Shareholders of record on Thursday, July 24th will be issued a dividend of $0.90 per share. This is a positive change from Marsh & McLennan Companies's previous quarterly dividend of $0.82. This represents a $3.60 dividend on an annualized basis and a yield of 1.68%. Marsh & McLennan Companies's payout ratio is currently 39.95%.
Analysts Set New Price Targets
MMC has been the topic of several recent research reports. Keefe, Bruyette & Woods cut their target price on Marsh & McLennan Companies from $215.00 to $214.00 and set an "underperform" rating on the stock in a report on Wednesday. Jefferies Financial Group lifted their target price on Marsh & McLennan Companies from $237.00 to $244.00 and gave the stock a "hold" rating in a report on Friday, April 11th. UBS Group lifted their price objective on Marsh & McLennan Companies from $259.00 to $261.00 and gave the stock a "buy" rating in a research report on Wednesday, April 9th. Redburn Atlantic assumed coverage on Marsh & McLennan Companies in a research report on Tuesday, March 25th. They issued a "buy" rating and a $281.00 price objective for the company. Finally, Barclays lowered their price objective on Marsh & McLennan Companies from $249.00 to $233.00 and set an "equal weight" rating for the company in a research report on Monday. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $240.50.
Read Our Latest Research Report on Marsh & McLennan Companies
Marsh & McLennan Companies Profile
(
Free Report)
Marsh & McLennan Cos., Inc is a professional services firm, which engages in offering clients advice and solutions in risk, strategy, and people. It operates through the Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment is involved in risk management activities, as well as insurance and reinsurance broking and services.
Featured Stories

Before you consider Marsh & McLennan Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.
While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.